Digirad Financial Diagnostics

Digirad Corporation -- USA Stock  

USD 1.38  0.005  0.36%

Digirad Corporation diagnostics interface makes it easy to digest most current publicly released information about Digirad as well as get updates on important government artifacts including earning estimates, SEC corporate filings and announcements. This module also helps to analysis Digirad price relationship with some important fundamental indicators such as market cap and management efficiency.
About 56.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 1.05. Some equities with similar Price to Book (P/B) outperform the market in the long run. Digirad Corporation recorded loss per share of 1.79. This company last dividend was issued on 2018-02-14. Digirad Corporation provides healthcare solutions in the United States. Digirad Corporation was founded in 1985 and is headquartered in Suwanee, Georgia. Digirad operates under Medical Devices classification in USA and traded on NASDAQ General Markets. It employs 515 people. To learn more about DIGIRAD CORPORATI call Matthew Molchan at 858-726-1600 or check out http://www.digirad.com.

Digirad Alerts

Digirad may become a speculative penny stock
Digirad has high likelihood to experience some financial distress in the next 2 years
Digirad has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations
The company reported previous year revenue of 118.34 M. Net Loss for the year was (35.73 M) with profit before overhead, payroll, taxes, and interest of 28.4 M.
About 56.0% of the company shares are held by institutions such as insurance companies

Digirad Upcoming Events

Upcoming Quarterly ReportMay 5, 2017
Next Earnings ReportJuly 27, 2017

Digirad EPS Estimate

EPSEstimate Date
Quarterly Estimate0.05May 5, 2017

Digirad SEC Filings

Financial Statements and Exhibits. Other Events
Unclassified Corporate Event
Unclassified Corporate Event
Unclassified Corporate Event
Unclassified Corporate Event
Financial Statements and Exhibits. Results of Operations and Financial Condition. Entry into a Material Definitive Agreement
Financial Statements and Exhibits. Results of Operations and Financial Condition
Financial Statements and Exhibits. Submission of Matters to a Vote of Security Holders. Amendments to Articles of Incorporation or Bylaws; and/or Change in Fiscal Year. Material Modifications to Rights of Security Holders

Digirad Thematic Classifications

Medical Equipment IdeaMedical Equipment
USA Equities from Medical Equipment industry as classified by Fama & French

Institutional Investors

Security TypeSharesValue
Amg National Trust BankCommon Shares50.8 K79 K
Albion Financial GroupCommon Shares13.1 K20 K
Fny Partners Fund LpCommon Shares6 K9 K
First Manhattan CoCommon Shares3.5 K5 K
Cannell Capital Llc 0Common Shares2.1 M5.4 M
Ariel Investments LlcCommon Shares1.2 M3.1 M
Dimensional Fund Advisors LpCommon Shares1.1 M2.7 M

Market Capitalization

The company currently falls under 'Micro-Cap' category with current market capitalization of 29.17 M.

Profitablity

The company has Profit Margin (PM) of (30.19) % which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (1.01) % which suggests for every $100 dollars of sales it generated a net operating loss of -0.01.

Management Efficiency

Digirad Corporation has return on total asset (ROA) of (0.86) % which means that it has lost $0.86 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (75.8) % meaning that it created substantial loss on money invested by shareholders.

Digirad Insider Trading Activities

Digirad Predictive Indicators

Digirad Corporate Filings

Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations
Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations
Annual report required by the U.S. Securities and Exchange Commission (SEC) of a company financial performance
Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations
Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations
Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations
Annual report required by the U.S. Securities and Exchange Commission (SEC) of a company financial performance
Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations

Trending Equities

What people are investing to
F   
 NYQ 
Purchased over 200 shares of
a day ago
Traded for 10.96
MSFT   
 NMS 
Purchased over 30 shares of
a day ago
Traded for 96.11
GM   
 NYQ 
Purchased over 70 shares of
a day ago
Traded for 37.77
DD   
 NYQ 
Purchased over 100 shares of
a day ago
Traded for 30.6
CRM   
 NYQ 
Purchased over 20 shares of
a day ago
Traded for 124.06
RKDA   
 NCM 
Purchased over 100 shares of
a day ago
Traded for 23.82

Generate Optimal Portfolios

Align your risk and return expectations
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Additionally see Investing Opportunities. Please also try Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.